UBS highlights increased expectations for share buybacks and EPS after CMD. Following this meeting with management, the analyst confirms his Neutral opinion on the stock and raises his price target to 532 Swiss francs (compared to 475 Swiss francs).
‘Zurich impresses with its ambitious three-year plan, but the valuation limits the upside potential. Share buybacks will be one-off,’ indicates UBS.
The Swiss insurance group has announced its new objectives for the period 2025-2027, which notably include a forecast of average annual growth of more than 9% in its basic earnings per share (EPS). ).
It also says it is targeting a return on equity (ROE) of at least 23%, as well as an amount of more than $19 billion in redistributions in the form of cash to its shareholders.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyzes disseminated by Cercle Finance only constitute a decision-making aid for investors. Cercle Finance cannot be held responsible directly or indirectly following the use of information and analyzes by readers. It is recommended that any uninformed person consult a professional advisor before making any investment. This indicative information does not in any way constitute an inducement to sell or a solicitation to buy.
Business
Related News :